zepbound tirzepatide Zepbound® - Prefilled Pen Zepbound® Vial | Hers

Katherine Birchenough

42) In SUSTAIN-6, patients treated with semaglutide had a lower risk of developing or worsening nephropathy, but a higher risk of complications from diabetic retinopathy than those receiving placebo ( In subsequent studies: PIONEER-6 and ELIXA the primary endpoints (death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, hospitalization for unstable angina) were not met in the GLP-1 RAs group, but a significant decrease in glycated hemoglobin was observed

However, studies in beta-3-AR knockout mice show AOD 9604 still increases energy expenditure and fat oxidation despite the lack of functional beta-3 receptors

"It's pushing on the bladder